Dr Amy B. Cadwallader joins Ethics Talk to discuss her article, coauthored with Kavitha Nallathambi: “How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?”
To be best able to respond if third parties in assisted reproduction contracts break their terms, physicians should familiarize themselves with the contracts, encourage all parties to self-disclose, and, failing that, disclose material information to the other party.
This month, Virtual Mentor theme issue editor, Katie Falloon, a medical student at the Duke University School of Medicine, interviewed Dr. Thomas Price about the ethical and regulatory issues associated with assisted reproductive technologies (ART).
Extensive resources are required for its implementation, but there is a strong case that bar-code medication-verification technology should be a required practice for demonstrating "meaningful use" of health information technology under the American Recovery and Reinvestment Act.
Anthony C. Rudine, MD, MBA and Jennifer P. Jennifer, PharmD
The authors recommend that pharmacists be consulted in the use of nephrotoxic parenteral medications in children to minimize any potential adverse reactions.
Transgender people planning a medical transition face decisions about family planning, fertility preservation, and how to access gender-affirming treatment.
AMA J Ethics. 2016;18(11):1119-1125. doi:
10.1001/journalofethics.2016.18.11.pfor2-1611.